Jim Simons Eli Lilly & CO Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Eli Lilly & CO stock. As of the latest transaction made, Renaissance Technologies LLC holds 130,178 shares of LLY stock, worth $118 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

130,178

Previous 273,863 52.47%

Holding current value

$118 Million

Previous $160 Million 36.56%

% of portfolio

0.16%

Previous 0.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $85.1 Million - $114 Million	-143,685 Reduced 52.47%	130,178 $101 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $72.7 Million - $85.7 Million	138,399 Added 102.17%	273,863 $160 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $53.2 Million - $73.4 Million	122,455 Added 941.31%	135,464 $72.8 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $155 Million - $207 Million	-440,571 Reduced 97.13%	13,009 $6.1 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $99.3 Million - $117 Million	-319,774 Reduced 41.35%	453,580 $156 Million

Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $77.6 Million - $90.4 Million	-241,293 Reduced 23.78%	773,354 $283 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $182 Million - $207 Million	613,764 Added 153.1%	1,014,647 $328 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $82.8 Million - $97.3 Million	297,183 Added 286.58%	400,883 $130 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $21.2 Million - $26.3 Million	-90,247 Reduced 46.53%	103,700 $29.7 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $193 Million - $240 Million	-859,500 Reduced 81.59%	193,947 $53.6 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $214 Million - $264 Million	967,347 Added 1123.52%	1,053,447 $243 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $26.5 Million - $34.3 Million	-146,847 Reduced 63.04%	86,100 $19.8 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $38.3 Million - $49.6 Million	232,947 New	232,947 $43.5 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $62.8 Million - $83.1 Million	-481,547 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $19.4 Million - $22.4 Million	-132,400 Reduced 21.57%	481,547 $71.3 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $54.5 Million - $65.6 Million	399,347 Added 186.09%	613,947 $101 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $25.5 Million - $31.6 Million	214,600 New	214,600 $29.8 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $17.4 Million - $21.5 Million	-162,699 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $229 Million - $249 Million	-2,145,902 Reduced 92.95%	162,699 $18.2 Million
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $175 Million - $205 Million	1,583,947 Added 218.58%	2,308,601 $256 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $79.5 Million - $93.5 Million	713,854 Added 6609.76%	724,654 $94 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $1.14 Million - $1.28 Million	10,800 New	10,800 $1.25 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account